Ergoteles’s Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share TCOA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,153
Closed -$1K 1994
2022
Q3
$1K Buy
+13,153
New +$1.76K ﹤0.01% 1490

Other funds holding TCOA.WS

Ergoteles's TCOA.WS Position: Q4 2022 in Review

Ergoteles sold out of Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (TCOA.WS) in Q4 2022, closing a stake of 13,153 shares — an estimated $1K sold.

Ergoteles first reported a position in TCOA.WS in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 21 funds tracked by Wall St. Rank hold TCOA.WS as of Q4 2022.

  • Ergoteles reported no remaining Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 13,153 Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $1K.
  • Ergoteles first reported a position in Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
  • Ergoteles's Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $1K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.